Literature DB >> 9628283

Hyperexcitability to sulphonylurea in MODY3.

O Søvik, P Njølstad, I Følling, J Sagen, B N Cockburn, G I Bell.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9628283     DOI： 10.1007/s001250050956

Source DB:  PubMed          Journal:  Diabetologia        ISSN： 0012-186X            Impact factor:   10.122


× No keyword cloud information.
  12 in total

1.  To: Lindner T, Cockburn BN, Bell GI (1999). Molecular genetics of MODY in Germany. Diabetologia 42: 121-123.

Authors:  F Ziemssen; C Bellanné-Chantelot; M Osterhoff; H Schatz; A F H Pfeiffer
Journal:  Diabetologia       Date:  2002-02       Impact factor: 10.122

Review 2.  Approach to the patient with atypical diabetes.

Authors:  Devin W Steenkamp; Sara M Alexanian; Elliot Sternthal
Journal:  CMAJ       Date:  2014-01-06       Impact factor: 8.262

3.  Where to for precision treatment of HNF1A-MODY?

Authors:  Caroline Bonner; Chiara Saponaro
Journal:  Diabetologia       Date:  2022-04-12       Impact factor: 10.460

4.  Pharmacogenetics of Anti-Diabetes Drugs.

Authors:  Johanna K Distefano; Richard M Watanabe
Journal:  Pharmaceuticals (Basel)       Date:  2010-08-01

5.  Association of a low-frequency variant in HNF1A with type 2 diabetes in a Latino population.

Authors:  Karol Estrada; Ingvild Aukrust; Lise Bjørkhaug; Noël P Burtt; Josep M Mercader; Humberto García-Ortiz; Alicia Huerta-Chagoya; Hortensia Moreno-Macías; Geoffrey Walford; Jason Flannick; Amy L Williams; María J Gómez-Vázquez; Juan C Fernandez-Lopez; Angélica Martínez-Hernández; Silvia Jiménez-Morales; Federico Centeno-Cruz; Elvia Mendoza-Caamal; Cristina Revilla-Monsalve; Sergio Islas-Andrade; Emilio J Córdova; Xavier Soberón; María E González-Villalpando; E Henderson; Lynne R Wilkens; Loic Le Marchand; Olimpia Arellano-Campos; Maria L Ordóñez-Sánchez; Maribel Rodríguez-Torres; Rosario Rodríguez-Guillén; Laura Riba; Laeya A Najmi; Suzanne B R Jacobs; Timothy Fennell; Stacey Gabriel; Pierre Fontanillas; Craig L Hanis; Donna M Lehman; Christopher P Jenkinson; Hanna E Abboud; Graeme I Bell; Maria L Cortes; Michael Boehnke; Clicerio González-Villalpando; Lorena Orozco; Christopher A Haiman; Teresa Tusié-Luna; Carlos A Aguilar-Salinas; David Altshuler; Pål R Njølstad; Jose C Florez; Daniel G MacArthur
Journal:  JAMA       Date:  2014-06-11       Impact factor: 56.272

Review 6.  New opportunities: harnessing induced pluripotency for discovery in diabetes and metabolism.

Authors:  Adrian Kee Keong Teo; Amy J Wagers; Rohit N Kulkarni
Journal:  Cell Metab       Date:  2013-09-12       Impact factor: 27.287

Review 7.  Monogenic models: what have the single gene disorders taught us?

Authors:  Tomasz Klupa; Jan Skupien; Maciej T Malecki
Journal:  Curr Diab Rep       Date:  2012-12       Impact factor: 4.810

8.  Exome sequencing and genetic testing for MODY.

Authors:  Stefan Johansson; Henrik Irgens; Kishan K Chudasama; Janne Molnes; Jan Aerts; Francisco S Roque; Inge Jonassen; Shawn Levy; Kari Lima; Per M Knappskog; Graeme I Bell; Anders Molven; Pål R Njølstad
Journal:  PLoS One       Date:  2012-05-25       Impact factor: 3.240

9.  Clinical features and treatment of maturity onset diabetes of the young (MODY).

Authors:  Daphne Sl Gardner; E Shyong Tai
Journal:  Diabetes Metab Syndr Obes       Date:  2012-05-01       Impact factor: 3.168

10.  The molecular mechanisms and pharmacotherapy of ATP-sensitive potassium channel gene mutations underlying neonatal diabetes.

Authors:  Veronica Lang; Peter E Light
Journal:  Pharmgenomics Pers Med       Date:  2010-11-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.